Could Legume-Enriched bread help tame blood sugar?
NCT ID NCT07652320
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether replacing some wheat flour with legume flours (chickpea, pea, or lentil) in Arabic bread can reduce blood sugar spikes after eating. Overweight or obese adults aged 18–65 will consume different breads and have their blood glucose and appetite measured. The goal is to see if these alternative flours offer a healthier option for blood sugar control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
legume-enriched bread (chickpea, pea, or lentil flour blend)
What this could lead to
If legume-enriched bread lowers blood sugar spikes, it could offer a simple dietary swap to help manage glucose levels and reduce diabetes risk.
What could go wrong
This is a small, early-stage trial with only 14 participants, so results may not apply broadly. The breads may not taste acceptable or show meaningful differences.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
School of Biosciences, University of Nottingham, Sutton Bonington Campus, United Kingdom
Nottingham, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Contact